Literature DB >> 32908829

Inflammatory Myofibroblastic Tumour.

Pedro Pimentel Duarte1, Rafaela Sousa1, Mariana Chaves1, Natacha Amaral1, César Lourenço1.   

Abstract

Inflammatory myofibroblastic tumour (IMT) is a rare mesenchymal tumour. It is usually benign but may behave as a malignant tumour with multiple recurrences and metastases. We present the case of a young woman with weight loss associated with diffuse abdominal pain, who was shown to have a large pancreatic mass. Investigation revealed fusocellular mesenchymal neoplasia, compatible with the diagnosis of IMT. As the mass was unresectable, glucocorticoid therapy was initiated with an excellent response and regression of the tumour. LEARNING POINTS: Inflammatory myofibroblastic tumour (IMT) is a rare entity.Since IMT can occur in different locations, its clinical presentation is varied, with non-specific symptoms.Prognosis is usually benign, but relapse and metastasis have been reported. © EFIM 2020.

Entities:  

Keywords:  Abdominal pain; inflammatory myofibroblastic tumour; neoplasm; retroperitoneal space

Year:  2020        PMID: 32908829      PMCID: PMC7473689          DOI: 10.12890/2020_001712

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  10 in total

Review 1.  Inflammatory Myofibroblastic Tumors: Current Update.

Authors:  Venkateswar R Surabhi; Steven Chua; Rajan P Patel; Naoki Takahashi; Neeraj Lalwani; Srinivasa R Prasad
Journal:  Radiol Clin North Am       Date:  2016-03-12       Impact factor: 2.303

Review 2.  Inflammatory myofibroblastic tumors.

Authors:  Stephen J Kovach; Anne C Fischer; Philip J Katzman; Rabih M Salloum; Stephen E Ettinghausen; Ralph Madeb; Leonidas G Koniaris
Journal:  J Surg Oncol       Date:  2006-10-01       Impact factor: 3.454

3.  Inflammatory tumour of the retroperitoneum--a case report.

Authors:  V P Mali; H C Tan; D Loh; K Prabhakaran
Journal:  Ann Acad Med Singap       Date:  2005-11       Impact factor: 2.473

4.  An isolated inflammatory myofibroblastic tumor of adrenal gland.

Authors:  Ghadah Al Sannaa; Jana L Wimmer; Alberto G Ayala; Jae Y Ro
Journal:  Ann Diagn Pathol       Date:  2016-08-12       Impact factor: 2.090

5.  One case of inflammatory myofibroblastic tumor--a case report.

Authors:  Chunze Zhang; Chun-Jie Li; Wen-Kang Zong; Mei-Lin Xu; Guan-Wei Fan
Journal:  J Cancer Res Ther       Date:  2015-08       Impact factor: 1.805

Review 6.  Inflammatory myofibroblastic tumours: where are we now?

Authors:  B C Gleason; J L Hornick
Journal:  J Clin Pathol       Date:  2007-10-15       Impact factor: 3.411

7.  Retroperitoneal inflammatory myofibroblastic tumor.

Authors:  Suresh V S Attili; C Rama Chandra; Dadhich K Hemant; Poonamalle P Bapsy; Clementeena RamaRao; G Anupama
Journal:  World J Surg Oncol       Date:  2005-10-08       Impact factor: 2.754

8.  Retroperitoneal Inflammatory Myofibroblastic Tumor: Case Report and Immunohistochemistry Study.

Authors:  Sonia Ziadi; Mounir Trimeche; Sarra Mestiri; Wafa Joma; Moncef Mokni; Rached Lataif; Badreddine Sriha; Sadok Korbi
Journal:  World J Oncol       Date:  2010-04-30

9.  ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis.

Authors:  Jun Fan; Bo Huang; Xiuping Yang; Ming Yang; Jun He; Xiu Nie
Journal:  Diagn Pathol       Date:  2017-09-18       Impact factor: 2.644

10.  Retroperitoneal inflammatory myofibroblastic tumor: A case report.

Authors:  Oliveira Carlos; Costa Rui; Estêvão Amélia; Caseiro-Alves Filipe
Journal:  Eur J Radiol Open       Date:  2017-02-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.